Chemoinformatics-applications in food chemistry

Advances in Food and Nutrition Research

Volumn 58, Issue , 2009, Pages 33-56

  Martinez Mayorga, Karina ^a   Medina Franco, Jose L ^a  

^a TORREY PINES INSTITUTE FOR MOLECULAR STUDIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BIOLOGY; CHEMICAL MODEL; CHEMISTRY; CONFORMATION; DRUG DEVELOPMENT; FACTUAL DATABASE; FOOD ANALYSIS; FOOD HANDLING; HUMAN; METHODOLOGY; QUANTITATIVE STRUCTURE ACTIVITY RELATION; REVIEW;

ANIMALS; CHEMISTRY, AGRICULTURAL; COMPUTATIONAL BIOLOGY; DATABASES, FACTUAL; DRUG DISCOVERY; FOOD ANALYSIS; FOOD TECHNOLOGY; HUMANS; MODELS, CHEMICAL; MOLECULAR CONFORMATION; QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77953623077     PISSN: 10434526     EISSN: None     Source Type: Book Series    
DOI: 10.1016/S1043-4526(09)58002-3     Document Type: Article

References (66)

1. Alvarez, J. and Shoichet, B. (2005). "Virtual Screening in Drug Discovery". Taylor & Francis Group, LLC CRC Press, Boca Raton, FL.
2. Amoore, J. E. (1963). Specific anosmia: A clue to the olfactory code. Nature 214, 1095-1098.
3. Amoore, J. E. (1967). Specific anosmia: A clue to the olfactory code. Nature 214, 1095-1098.
4. Amoore, J. E. (1971). Stereocehmical and vibrational theories of odour. Nature 233, 270-271.
5. Amoore, J. E., Palmieri, G., and Wanke, E. (1967). Molecular shape and odor: Pattern analysis by PAPA. Nature 216, 1084-1087.
6. Austin, C. P., Brady, L. S., Insel, T. R., and Collins, F. S. (2004). Molecular biology: NIH molecular libraries initiative. Science 306, 1138-1139.
7. Berman, H. M., Westbrook, J., Feng, Z., Gilliland, G., Bhat, T. N., Weissig, H., Shindyalov, I. N., and Bourne, P. E. (2000). The Protein Data Bank. Nucl. Acids Res. 28, 235-242.
8. Bhattacharya, S., Hall, S. E., and Vaidehi, N. (2008). Agonist-induced conformational changes in bovine rhodopsin: Insight into activation of G-protein-coupled receptors. J. Mol. Biol. 382, 539-555.
9. Brown, F. K. (1998). Chemoinformatics: What is it and how does it impact drug discovery? Ann. Rep. Med. Chem. 33, 375-384.
10. Buck, L. and Axel, R. (1991). A novel multigene family may encode odorant receptors: A molecular basis for odor recognition. Cell 65, 175-187.
11. Chastrette, M. (1998). Data management in olfactation studies. SAR QSAR Environ. Res. 8, 157-181.
12. Cherezov, V., Rosenbaum, D. M., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Kuhn, P., Weis, W. I., Kobilka, B. K., and Stevens, R. C. (2007). High-resolution crystal structure of an engineered human 2-adrenergic G protein coupled receptor. Science 318, 1258-1265.
13. Cong, M., Perry, S. J., Hu, L. A., Hanson, P. I., Claing, A., and Lefkowitz, R. J. (2001). Binding of the beta2 adrenergic receptor to N-ethylmaleimide-sensitive factor regulates receptor recycling. J. Biol. Chem. 276, 45145-45152.
14. Dixon, S. L., Smondyrev, A. M., Knoll, E. H., Rao, S. N., Shaw, D. E., and Friesner, R. A. (2006). PHASE: A new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results. J. Comput. Aid. Mol. Des. 20, 647-671.
15. Dobson, C. M. (2004). Chemical space and biology. Nature 432, 824-828.
16. Dunkel, M., Schmidt, U., Struck, S., Berger, L., Gruening, B., Hossbach, J., Jaeger, I. S., Effmert, U., Piechulla, B., Eriksson, R., Knudsen, J., and Preissner, R. (2009). SuperScent-A database of flavors and scents. Nucl. Acids Res. 37, pp. D291-D294.
17. Dziuba, J., Minkiewicz, P., Nalecz, D., and Iwaniak, A. (1999). Database of biologically active peptide sequences. Nahrung 43, 190-195.
18. Glide (2008). Schrödinger, LLC, New York, NY, version 5.0.
19. Irwin, J. J. and Shoichet, B. K. (2005). ZINC-A free database of commercially available compounds for virtual screening. J. Chem. Inf. Model. 45, 177-182.
20. Johnson, M. andMaggiora, G. M. (1990). "Concepts and Applications of Molecular Similarity". Wiley, New York.
21. Kirchmair, J., Ristic, S., Eder, K., Markt, P., Wolber, G., Laggner, C., and Langer, T. (2007). Fast and efficient in silico 3D screening: Toward maximum computational efficiency of pharmacophore-based and shape-based approaches. J. Chem. Inf. Model. 47, 2182-2196.
22. Kitchen, D. B., Decornez, H., Furr, J. R., and Bajorath, J. (2004). Docking and scoring in virtual screening for drug discovery: Methods and applications. Nat. Rev. Drug Discov. 3, 935-949.
23. Kraft, P., Bajgrowicz, J. A., Denis, C., and Frater, G. (2000). Odds and trends: Recent developments in the chemistry of odorants. Angew. Chem. Int. Ed. 39, 2980-3010.
24. Kubinyi, H. (1997a). QSAR and 3D QSAR in drug design. 1. Methodology. Drug Discov. Today 2, 457-467.
25. Kubinyi, H. (1997b). QSAR and 3D QSAR in drug design. 2. Applications and problems. Drug Discov. Today 2, 538-546.
26. Leach, A. R. and Willet, V. J. (2003). "An Introduction to Chemoinformatics". Kluwer Academic Publishers, Dordrecht, The Netherlands.
27. Maggiora, G. M. (2006). On outliers and activity cliffs-Why QSAR often disappoints. J. Chem. Inf. Model. 46, 1535.
28. Martinez-Mayorga, K., Medina-Franco, J. L., Giulianotti, M. A., Pinilla, C., Dooley, C. T., Appel, J. R., and Houghten, R. (2008). Conformation-opioid activity relationships of bicyclic guanidines from 3D similarity analysis. Bioorg. Med. Chem. 16, 5932-5938.
29. Masciocchi, J., Frau, G., Fanton, M., Sturlese, M., Floris, M., Pireddu, L., Palla, P., Cedrati, F., Rodriguez-Tome, P., and Moro, S. (2009). MMsINC: A large-scale chemoinformatics database. Nucl. Acids Res. 37, D284-D290.
30. McGann, M. R., Almond, H. R., Nicholls, A., Grant, J. A., and Brown, F. K. (2003). Gaussian docking functions. Biopolymers 68, 76-90.
31. Medina-Franco, J. L., Maggiora, G. M., Gulianotti, M. A., Pinilla, C., and Houghten, R. A. (2007). A similarity-based data-fusion approach to the visual characterization and comparison of compound databases. Chem. Biol. Drug. Des. 70, 393-412.
32. Medina-Franco, J. L., Martínez-Mayorga, K., Bender, A., Marín, R. M., Giulianotti, M. A., Pinilla, C., and Houghten, R. A. (2009). Characterization of activity landscapes using 2D and 3D similarity methods: Consensus activity cliffs. J. Chem. Inf. Model. 49, 477-491.
33. Medina-Franco, J. L., Martinez-Mayorga, K., Giulianotti, M. A., Houghten, R. A., and Pinilla, C. (2008). Visualization of the chemical space in drug discovery. Curr. Comput. Aid. Drug Des. 4, 323-334.
34. Miller, M. A. (2002). Chemical database techniques in drug discovery. Nat. Rev. Drug Discov. 1, 220-227.
35. Moncrieff, R. W. (1967). "The Chemical Sence". CRC Press, Cleveland.
36. Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., and Olson, A. J. (2009). AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility. J. Comput. Chem. Doi: 10.1002/jcc.21256.
37. Nakamichi, H. and Okada, T. (2006a). Chrystallographic analysis of primary visual photochemistry. Angew. Chem. Int. Ed. 45, 4270-4273.
38. Nakamichi, H. and Okada, T. (2006b). Local peptide movement in the photoreaction intermediate of rhodopsin. Proc. Natl. Acad. Sci. USA 103, 12729-12734.
39. Omega version 2.2.1 OpenEye Scientific Software: Santa Fe, NM, USA, www.eyesopen.com..
40. Palczewski, K., Kumasaka, T., Hori, T., Behnke, C. A., Motoshima, H., Fox, B. A., Trong, I. L., Teller, D. C., Okada, T., Stenkamp, R. E., Yamamoto, M., and Miyano, M. (2000). Crystal structure of rhodopsin: A G protein-coupled receptor. Science 289, 739-745.
41. Paris, G. (2000). "Balancing the Needs of the Recruiters and the Aims of the Educators". http://www.warr.com.
42. Peltason, L. and Bajorath, J. (2007). Molecular similarity analysis uncovers heterogeneous structure-activity relationships and variable activity landscapes. Chem. Biol. 14, 489-497.
43. Peltason, L. and Bajorath, J. (2008). Molecular similarity analysis in virtual screening. In "Chemoinformatics Approaches to Virtual Screening", (A. Varnek and A. Tropsha, eds), pp. 120-147. RSC Publishing, Cambridge, UK.
44. Pripp, A. H. (2007). Docking and virtual screening of ACE inhibitory dipeptides. Eur. Food. Res. Technol. 225, 589-592.
45. Rasmussen, S. G. F., Choi, H.-J., Rosenbaum, D. M., Kobilka, T. S., Thian, F. S., Edwards, P. C., Burghammer, M., Ratnala, V. R. P., Sanishvili, R., Fischetti, R. F., Schertler, G. F. X., Weis, W. I., et al. (2007). Crystal structure of the human beta2 adrenergic G-protein-coupled receptor. Nature 450, 383-387.
46. ROCS version 2.3.1 OpenEye Scientific Software: Santa Fe, NM, USA, www.eyesopen.com.
47. Rosenbaum, D. M., Cherezov, V., Hanson, M. A., Rasmussen, S. G. F., Thian, F. S., Kobilka, T. S., Choi, H.-J., Yao, X.-J., Weis, W. I., Stevens, R. C., and Kobilka, B. K. (2007). GPCR engineering yields high-resolution structural insights into beta2 adrenergic receptor function. Science 318, 1266-1273.
48. Ruprecht, J. J., Mielke, T., Vogel, R., Villa, C., and Schertler, G. F. X. (2004). Electron crystallography reveals the structure of metarhodopsin I. EMBO J. 23, 3609-3620.
49. Salom, D., Lodowski, D. T., Stenkamp, R. E., Trong, I. L., Golczak, M., Jastrzebska, B., Harris, T., Ballesteros, J. A., and Palczewski, K. (2006). Crystal structure of a photoactivated deprotonated intermediate of rhodopsin. Proc. Natl. Acad. Sci. USA 103, 16123-16128.
50. Scior, T., Bernard, P., Medina-Franco, J. L., and Maggiora, G. M. (2007). Large compound databases for structure-activity relationships studies in drug discovery. Mini-Rev. Med. Chem. 7, 851-860.
51. Sell, C. S. (2006). On the unpredictability of odor. Angew. Chem. Int. Ed. 45, 6254-6261.
52. Sell, C. S. (2008). Rational odorant design: Fantasy or feasibility? Perfum. Flavor. 33, 48-52.
53. Singh, N., Guha, R., Giulianotti, M. A., Pinilla, C., Houghten, R. A., and Medina-Franco, J. L. (2009). Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J. Chem. Inf. Model. 49, 1010-1024.
54. Sprous, D. G. and Salemme, F. R. (2007). A comparison of the chemical properties of drugs and FEMA/FDA notified GRAS chemical compounds used in the food industry. Food Chem. Toxicol. 45, 1419-1427.
55. Tikhonova, I. G., Best, R. B., Engel, S., Gershengorn, M. C., Hummer, G., and Costanzi, S. (2008). Atomistic insights into rhodopsin activation from a dynamic model. J. Am. Chem. Soc. 130, 10141-10149.
56. van Drie, J. H. (2003). Pharmacophore discovery-Lessons learned. Curr. Pharm. Desgn. 9, 1649.
57. Varnek, A. and Tropsha, A. (2008). "Chemoinformatics Approaches to Virtual Screening". RSC Publishing, Cambridge, UK.
58. Wermuth, C. G. (2008). The Practice of Medicinal Chemistry. Elsevier, Academic Press, London, UK.
59. Wild, D. J. and Wiggings, G. D. (2006). Challenges for chemoinformatics education in drug discovery. Drug Discov. Today 11, 436-439.
60. Willett, P. (2006a). Enhancing the effectiveness of ligand-based virtual screening using data fusion. QSAR Comb. Sci. 25, 1143-1152.
61. Willett, P. (2006b). Similarity-based virtual screening using 2D fingerprints. Drug Discov. Today 11, 1046-1053.
62. Willett, P., Barnard, J. M., and Downs, G. M. (1998). Chemical similarity searching. J. Chem. Inf. Comput. Sci. 38, 983-996.
63. Wishart, D. S., Knox, C., Guo, A. C., Cheng, D., Shrivastava, S., Tzur, D., Gautam, B., and Hassanali, M. (2008). DrugBank: A knowledgebase for drugs, drug actions and drug targets. Nucl. Acids Res. 36, D901-D906.
64. Yongye, A. B., Appel, J. R., Giulianotti, M., Dooley, C. T., Medina-Franco, J. L., Nefzi, A., Houghten, R., and Martinez-Mayorga, K. (2009). Identification, binding mode prediction and structure-activity relationships of potent triamine and piperazine opioid ligands. Bioorg. Med. Chem. 17, 5583-5597.
65. Zarzo, M. (2007). The sense of smell: Molecular basis of odorant recognition. Biol. Rev. 82, 455-479.
66. Zozulya, S., Echeverri, F., and Nguyen, T. (2001). The human olfactory receptor repertoire. Genome Biol. 2, 18.11-18.12.